トヨタ、8月の国内工場の稼働について発表

ENGLISH
|
JAPANESE
|
CONNECT WITH US:

2022年07月29日 15時00分

Source: Toyota Motor Corporation

トヨタ、8月の国内工場の稼働について発表

豊田, 2022年07月29日 - (JCN Newswire) - 新型コロナウイルス感染拡大等に伴う部品供給不足による生産計画の度重なる見直しにより、お待ちいただいているお客様や、仕入先及び関係の皆さまにはご迷惑、ご不便をおかけし、改めて心からお詫び申し上げます。

このたび、愛知県を中心とした豪雨被害による、一部仕入先からの部品調達への影響に伴う国内工場の稼働停止について、2工場での稼働再開および、1工場での稼働停止の延長を決定いたしました。今回の決定による影響台数は約1,000台となり、7/27以降の公表分と合わせて豪雨被害による影響台数は約5,200台です。

半導体不足およびコロナウイルス感染拡大による影響等により、先を見通すことが依然困難な状況のため、生産計画が下振れする可能性もありますが、部品供給を精査し、できるだけ急減産を抑えながら、1日でも早く1台でも多くお客様にお届けできるよう、引き続き、努力してまいります。

本リリースの詳細は下記URLをご参照ください。
https://global.toyota/jp/newsroom/corporate/37723683.html

概要：トヨタ自動車株式会社

詳細は http://toyota.jp/ をご覧ください。

Source: Toyota Motor Corporation
セクター: 自動車

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest Release

CleverTap

CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 22, 2024 22:42 JST

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST

NaaS Technology Inc.

NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST

Honda Motor Co, Ltd

Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST

Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST

Lexaria Bioscience

ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST

Mitsubishi Heavy Industries, Ltd.

Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST

Eisai

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST

Eisai

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST

Kingsoft Corporation Limited

Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST

Olympus

NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST

Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST

CleverTap

CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST

NEC Corporation

World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST

Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST

Toyota Motor Corporation

Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST

COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST

Mitsubishi Heavy Industries, Ltd.

Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
Nov 15, 2024 18:58 JST

Eisai

Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
Nov 15, 2024 17:33 JST

Eisai

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Nov 15, 2024 14:31 JST

More Latest Release >>